Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Aspire Biopharma Holdings Inc (ASBP)

Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,923
  • Shares Outstanding, K 2,687
  • Annual Sales, $ 0 K
  • Annual Income, $ -12,540 K
  • EBIT $ -17 M
  • EBITDA $ -17 M
  • 60-Month Beta 0.81
  • Price/Sales 931.32
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4100 +21.28%
on 01/29/26
6.8400 -75.00%
on 01/07/26
-3.9700 (-69.89%)
since 12/30/25
3-Month
1.4100 +21.28%
on 01/29/26
15.8680 -89.22%
on 10/31/25
-13.3460 (-88.64%)
since 10/30/25
52-Week
1.4100 +21.28%
on 01/29/26
632.0000 -99.73%
on 02/12/25
-470.2900 (-99.64%)
since 01/30/25

Most Recent Stories

More News
Aspire Biopharma Secures Agreement with Microsize for Development of Novel Sublingual Aspirin

Microsize brings over thirty years of expertise in specialized particle size engineering for the pharmaceutical industry, from pre-clinical development to full-scale GMP commercial manufacturing.

ASBPW : 0.0185 (+8.19%)
ASBP : 1.8975 (+29.97%)
Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Powder Formulation of Clopidogrel (Generic Plavix(R)) to Address Gastric Bleeding Risks

New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel.

ASBPW : 0.0185 (+8.19%)
ASBP : 1.8975 (+29.97%)
Aspire Biopharma Scales Consumer Division with Delivery of Two Million BUZZ BOMB(TM) Units Featuring Modernized Brand Identity

Strategic inventory of 100,000 20-packs now available to meet increasing demand for rapid-onset sublingual caffeine technology

ASBPW : 0.0185 (+8.19%)
ASBP : 1.8975 (+29.97%)
Aspire Biopharma's Unveils Bold New Era for BUZZ BOMB(TM) Caffeine with Dynamic Website and Packaging Redesign

New streamlined, mobile-optimized shopping experience, allows consumers to purchase BUZZ BOMBâ„¢ directly, access exclusive promotions and engage with the brand through educational and lifestyle content...

ASBPW : 0.0185 (+8.19%)
ASBP : 1.8975 (+29.97%)
Aspire Biopharma Files Provisional Patent Application for Industry-First Sublingual Formulation of Alprazolam - Generic Xanax(R) - for Rapid Anxiety Relief

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and generalized anxiety disorders

ASBPW : 0.0185 (+8.19%)
ASBP : 1.8975 (+29.97%)
Aspire Biopharma Announces Reverse Stock Split

ESTERO, FL / ACCESS Newswire / January 14, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery...

ASBPW : 0.0185 (+8.19%)
ASBP : 1.8975 (+29.97%)
Aspire Biopharma Announces Successful Pre-IND Meeting with FDA for High-Dose Sublingual Aspirin (OTASA)

FDA feedback supports 505(b)(2) filing in H2 2026; No additional studies required beyond current planned 32-subject clinical trial

ASBPW : 0.0185 (+8.19%)
ASBP : 1.8975 (+29.97%)
Aspire Biopharma Welcomes Elite Ultra-Runner Ashley Paulson as Global Brand Ambassador for BUZZ BOMB(R) Caffeine

A highly decorated endurance athlete, Ashley embodies the grit, energy, and rapid performance that BUZZ BOMB® was designed to support

ASBPW : 0.0185 (+8.19%)
ASBP : 1.8975 (+29.97%)
Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, received...

ASBPW : 0.0185 (+8.19%)
ASBP : 1.8975 (+29.97%)
Aspire Biopharma Provides Q3 2025 Business Update

ESTERO, FL / ACCESS Newswire / December 4, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, today...

ASBPW : 0.0185 (+8.19%)
ASBP : 1.8975 (+29.97%)

Business Summary

Aspire Biopharma Inc. is a privately held, early-stage biopharmaceutical technology company. It engaged in the business of developing and marketing a disruptive technology for novel delivery mechanisms for FDA approved drugs, nutraceuticals and supplements. Aspire Biopharma Inc., formerly known as PowerUp...

See More

Key Turning Points

3rd Resistance Point 1.8433
2nd Resistance Point 1.7467
1st Resistance Point 1.6033
Last Price 1.8975
1st Support Level 1.3633
2nd Support Level 1.2667
3rd Support Level 1.1233

See More

52-Week High 632.0000
Fibonacci 61.8% 391.1146
Fibonacci 50% 316.7050
Fibonacci 38.2% 242.2954
Last Price 1.8975
52-Week Low 1.4100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar